Sector ratings Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG 02:02:26 2026-08-18 EDT			5-day change	1st Jan Change
245.90 ^EUR	+2.08%		+6.40%	+43.09%

08-13	Charles River Laboratories International Insider Sold Shares Worth $1,038,657, According to a Recent SEC Filing	MT
08-10	TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LONZA GROUP AG	48.84B		AAA
REVOLUTION MEDICINES, INC.	45.44B	-	B	-	-
BEONE MEDICINES AG	41.22B		-
IQVIA HOLDINGS INC.	39.71B		AAA
CELLTRION, INC.	32.6B		A
ASCENDIS PHARMA A/S	16.25B	-	-	-	-
MEDPACE HOLDINGS, INC.	16.67B		BBB
EUROFINS SCIENTIFIC SE	14.08B		AA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	13.68B		AA
ICON PUBLIC LIMITED COMPANY	13.07B		AAA
PHARMARON BEIJING CO., LTD.	12.37B		AA
BIO-TECHNE CORPORATION	11.28B		AA
ABIVAX	10.57B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	10.51B	-	B	-	-
APOGEE THERAPEUTICS, INC.	10.15B	-	B	-	-
PROTAGONIST THERAPEUTICS, INC.	10.26B		BB		-
KYMERA THERAPEUTICS, INC.	10.1B	-	BBB	-	-
IONIS PHARMACEUTICALS, INC.	9.74B	-	A	-	-
TEMPUS AI, INC.	9.32B		A		-
Average	19.78B		A
Weighted average by Cap.			A